COMPOSITION COMPRISING FRACTIONS OR SUB-FRACTIONS OF LEISHMANIA PROMASTIGOTES OR LEISHMANIA AMASTIGOTES CALLED FUCOSE MANNOSE LIGAND (FML) AND SAPONIN, COMPOSITION FOR PREPARATION OF LEISHMANIASIS TRANSMISSION BLOCKING VACCINES IN HUMANS AND ANIMALS

The invention relates to a composition comprising Leishmania promastigotes or Leishmania amastigotes fractions or sub-fractions called "Fucose Mannose Ligand" (FML) and saponin. The invention also comprises the use of the composition for preparation of a blocking vaccine impeding Leishmani...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PALATNIK DE SOUZA, CLARISA B, CHEQUER BOU-HABIB, ELVIRA MARIA SARAIVA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to a composition comprising Leishmania promastigotes or Leishmania amastigotes fractions or sub-fractions called "Fucose Mannose Ligand" (FML) and saponin. The invention also comprises the use of the composition for preparation of a blocking vaccine impeding Leishmaniasis transmission in humans or animals. L'invention concerne une composition contenant des fractions ou des sous-fractions de promastigotes ou d'amastigotes de Leishmania désignées "ligand fucose-mannose" (FML) et saponine. Elle concerne également l'utilisation de cette composition afin de préparer un vaccin bloquant la transmission de la Leishmaniose chez l'homme ou chez l'animal.